June 3, 2023 Comments Off on New patent for Amgen Inc drug LUMAKRAS Posted in: Patent Added Annual Drug Patent Expirations for LUMAKRAS Lumakras is a drug marketed by Amgen Inc and is included in one NDA. It is available from one supplier. There are three patents…
The post New patent for Amgen Inc drug LUMAKRAS appeared first on DrugPatentWat…
June 3, 2023 Comments Off on New patent for Abbvie Endocrine drug LUPRON DEPOT-PED KIT Posted in: Patent Added Annual Drug Patent Expirations for LUPRON+DEPOT-PED+KIT Lupron Depot-ped Kit is a drug marketed by Abbvie Endocrine Inc and is included in one NDA. It is available from one supplier. The…
The post New patent for Abbvie Endocrine drug LUPRON DEPOT-PED K…
